Controversies in adjuvant endocrine therapy for pre- and post-menopausal women with breast cancer
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference43 articles.
1. Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer;Goldhirsch;J Clin Oncol,2003
2. Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial;The ATAC Trialists’ Group;Lancet Oncol,2008
3. A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer;Thurlimann;N Engl J Med,2005
4. A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer;Coombes;N Engl J Med,2004
5. Survival and safety of exemestane versus tamoxifen after 2–3 years tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial;Coombes;Lancet,2007
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Level of Adherence to Breast Cancer Molecular Subtyping among Women with Breast Cancer Attending Tertiary Health Facilities;Journal of Biosciences and Medicines;2023
2. Influence of Socioeconomic Profile on Uptake of Immunohistochemistry Services among Women with Breast Cancer Attending Tertiary Health Facilities;Journal of Biosciences and Medicines;2023
3. Influence of Cues to Action towards Uptake of Immunohistochemistry Services among Women with Breast Cancer Attending Tertiary Health Facilities;Journal of Biosciences and Medicines;2023
4. Information needs of post-menopausal women with hormone receptor positive early-stage breast cancer considering adjuvant endocrine therapy;Patient Education and Counseling;2013-10
5. Information for decision making by post-menopausal women with hormone receptor positive early-stage breast cancer considering adjuvant endocrine therapy;The Breast;2013-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3